Literature DB >> 26366541

Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ: Analysis of 2996 Women Treated With Breast-conserving Surgery for 30 Years.

Kimberly J Van Zee1, Preeti Subhedar, Cristina Olcese, Sujata Patil, Monica Morrow.   

Abstract

OBJECTIVE: Our goal was to investigate, in a large population of women with ductal carcinoma in situ (DCIS) and long follow-up, the relationship between margin width and recurrence, controlling for other characteristics.
BACKGROUND: Although DCIS has minimal mortality, recurrence rates after breast-conserving surgery are significant, and half are invasive. Positive margins are associated with increased risk of local recurrence, but there is no consensus regarding optimal negative margin width.
METHODS: We retrospectively reviewed a prospective database of DCIS patients undergoing breast-conserving surgery from 1978 to 2010. Univariate and Cox proportional hazard models were used to investigate the association between margin width and recurrence.
RESULTS: In this review, 2996 cases were identified, of which 363 recurred. Median follow-up for women without recurrence was 75 months (range 0-30 years); 732 were studied for ≥10 years. Controlling for age, family history, presentation, nuclear grade, number of excisions, radiotherapy (RT), endocrine therapy, and year of surgery, margin width was significantly associated with recurrence in the entire population. Larger negative margins were associated with a lower hazard ratio compared with positive margins. An interaction between RT and margin width was significant (P < 0.03); the association of recurrence with margin width was significant in those without RT (P < 0.0001), but not in those with RT (P = 0.95).
CONCLUSIONS: In women not receiving RT, wider margins are significantly associated with a lower rate of recurrence. Obtaining wider negative margins may be important in reducing the risk of recurrence in women who choose not to undergo RT and may not be necessary in those who receive RT.

Entities:  

Mesh:

Year:  2015        PMID: 26366541      PMCID: PMC4739638          DOI: 10.1097/SLA.0000000000001454

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  40 in total

1.  Margin width as a determinant of local control with and without radiation therapy for ductal carcinoma in situ (DCIS) of the breast.

Authors:  A C Neuschatz; T DiPetrillo; H Safaii; D Lowther; M Landa; D E Wazer
Journal:  Int J Cancer       Date:  2001       Impact factor: 7.396

2.  Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy.

Authors:  F A Vicini; L L Kestin; N S Goldstein; K L Baglan; J E Pettinga; A A Martinez
Journal:  J Surg Oncol       Date:  2001-04       Impact factor: 3.454

3.  Duct carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy.

Authors:  B McCormick; P P Rosen; D Kinne; L Cox; J Yahalom
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-07       Impact factor: 7.038

4.  Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

Authors:  N Bijker; J L Peterse; L Duchateau; J P Julien; I S Fentiman; C Duval; S Di Palma; J Simony-Lafontaine; I de Mascarel; M J van de Vijver
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

5.  Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial.

Authors:  Fredrik Wärnberg; Hans Garmo; Stefan Emdin; Veronica Hedberg; Linda Adwall; Kerstin Sandelin; Anita Ringberg; Per Karlsson; Lars-Gunnar Arnesson; Harald Anderson; Karin Jirström; Lars Holmberg
Journal:  J Clin Oncol       Date:  2014-10-13       Impact factor: 44.544

6.  Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age.

Authors:  K J Van Zee; L Liberman; B Samli; K N Tran; B McCormick; J A Petrek; P P Rosen; P I Borgen
Journal:  Cancer       Date:  1999-11-01       Impact factor: 6.860

7.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

8.  The influence of margin width on local control of ductal carcinoma in situ of the breast.

Authors:  M J Silverstein; M D Lagios; S Groshen; J R Waisman; B S Lewinsky; S Martino; P Gamagami; W J Colburn
Journal:  N Engl J Med       Date:  1999-05-13       Impact factor: 91.245

9.  RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.

Authors:  Beryl McCormick; Kathryn Winter; Clifford Hudis; Henry Mark Kuerer; Eileen Rakovitch; Barbara L Smith; Nour Sneige; Jennifer Moughan; Amit Shah; Isabelle Germain; Alan C Hartford; Afshin Rashtian; Eleanor M Walker; Albert Yuen; Eric A Strom; Jeannette L Wilcox; Laura A Vallow; William Small; Anthony T Pu; Kevin Kerlin; Julia White
Journal:  J Clin Oncol       Date:  2015-01-20       Impact factor: 44.544

10.  A prognostic index for ductal carcinoma in situ of the breast.

Authors:  M J Silverstein; M D Lagios; P H Craig; J R Waisman; B S Lewinsky; W J Colburn; D N Poller
Journal:  Cancer       Date:  1996-06-01       Impact factor: 6.860

View more
  31 in total

Review 1.  Trends and controversies in multidisciplinary care of the patient with breast cancer.

Authors:  Laura S Dominici; Monica Morrow; Elizabeth Mittendorf; Jennifer Bellon; Tari A King
Journal:  Curr Probl Surg       Date:  2016-11-29       Impact factor: 1.909

Review 2.  Management of Ductal Carcinoma In Situ (DCIS) of the Breast: Present Approaches and Future Directions.

Authors:  Lawrence J Solin
Journal:  Curr Oncol Rep       Date:  2019-03-05       Impact factor: 5.075

3.  ASO Author Reflections: Does Genomic Testing of DCIS Provide Added Value? And Is It Worth the Cost?

Authors:  Kimberly J Van Zee
Journal:  Ann Surg Oncol       Date:  2019-08-23       Impact factor: 5.344

Review 4.  Controversies in the Treatment of Ductal Carcinoma in Situ.

Authors:  Andrea V Barrio; Kimberly J Van Zee
Journal:  Annu Rev Med       Date:  2017-01-14       Impact factor: 13.739

Review 5.  De-Escalation of Locoregional Therapy in Low-Risk Disease for DCIS and Early-Stage Invasive Cancer.

Authors:  E Shelley Hwang; Lawrence Solin
Journal:  J Clin Oncol       Date:  2020-05-22       Impact factor: 44.544

6.  Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ.

Authors:  Monica Morrow; Kimberly J Van Zee; Lawrence J Solin; Nehmat Houssami; Mariana Chavez-MacGregor; Jay R Harris; Janet Horton; Shelley Hwang; Peggy L Johnson; M Luke Marinovich; Stuart J Schnitt; Irene Wapnir; Meena S Moran
Journal:  Pract Radiat Oncol       Date:  2016-06-24

7.  Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?

Authors:  Melissa Pilewskie; Michelle Stempel; Hope Rosenfeld; Anne Eaton; Kimberly J Van Zee; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2016-05-12       Impact factor: 5.344

Review 8.  The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.

Authors:  M Luke Marinovich; Lamiae Azizi; Petra Macaskill; Les Irwig; Monica Morrow; Lawrence J Solin; Nehmat Houssami
Journal:  Ann Surg Oncol       Date:  2016-08-15       Impact factor: 5.344

9.  ASO Author Reflections: Advising a Woman with Ductal Carcinoma In Situ Regarding Various Treatment Options-A Complex Decision.

Authors:  Anita Mamtani; Kimberly J Van Zee
Journal:  Ann Surg Oncol       Date:  2019-09-23       Impact factor: 5.344

10.  Does margin width impact breast cancer recurrence rates in women with breast conserving surgery for ductal carcinoma in situ?

Authors:  Devon Livingston-Rosanoff; Amy Trentham-Dietz; John M Hampton; Polly A Newcomb; Lee G Wilke
Journal:  Breast Cancer Res Treat       Date:  2021-06-15       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.